artus' ExpressArt kits finds global distributor
This article was originally published in Clinica
German company MWG Biotech has agreed to undertake the worldwide distribution of Hamburg-based artus' ExpressArt line of mRNA amplification kits. The devices are used to augment the total amount of input RNA to enable microarray experiments in the lab.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.